AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Boston Scientific Corp.
XNYS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S63L94
43.84▲ 1.11 (2.60%)
As of 2026-10-12
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
42.73
Day's Range
42.67 – 43.92
52-Week Range
41.39 – 105.65
Volume
13.0M
Avg Volume
18.9M
Share Statistics
Shares Outstanding
Employees
59.0K
Exchange
XNYS
Listed
1992-05-18
Share count as of July 30, 2026

Boston Scientific Corp. (BSX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Boston Scientific Corp. (BSX)
What is Boston Scientific Corp.'s Market Cap?
Boston Scientific Corp.'s Market Cap is $63.5B, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Enterprise Value?
Boston Scientific Corp.'s Enterprise Value is $75.5B, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Trailing P/E?
Boston Scientific Corp.'s Trailing P/E is 17.3×, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Price / Sales?
Boston Scientific Corp.'s Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s EV / Revenue?
Boston Scientific Corp.'s EV / Revenue is 3.6×, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s EV / EBITDA?
Boston Scientific Corp.'s EV / EBITDA is 13.3×, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Revenue (TTM)?
Boston Scientific Corp.'s Revenue (TTM) is $21.0B, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Net Income (TTM)?
Boston Scientific Corp.'s Net Income (TTM) is $3.7B, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s EBITDA?
Boston Scientific Corp.'s EBITDA is $5.6B, based on as-reported figures from SEC (XBRL) filings.
What is Boston Scientific Corp.'s Diluted EPS (TTM)?
Boston Scientific Corp.'s Diluted EPS (TTM) is 2.53, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BSXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+7.5%+11.6%+15.9%+20.3%
Cost of products sold (excluding amortization expense)
Gross profit
% of revenue70.7%69.5%69.6%69.9%
Operating expenses:
Selling, general and administrative expenses
Research and development expenses
Royalty expense
Amortization expense
Intangible asset impairment charges—
Contingent consideration net expense (benefit)
Restructuring net charges (credits)
Litigation-related net charges (credits)———
Operating expenses
% of revenue49.1%48.3%54.0%49.2%
Operating income (loss)
% of revenue21.6%21.2%15.6%20.7%
Other income (expense):
Interest expense
Other, net
Income (loss) before income taxes
Income tax expense (benefit)
Net income (loss)
% of revenue16.6%25.7%12.7%14.9%
Net income (loss) attributable to noncontrolling interests
Net income (loss) attributable to Boston Scientific common stockholders
Net income (loss) per common share — basic
Net income (loss) per common share — diluted